{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T06:45:27Z","timestamp":1789541127584,"version":"build-2803163510"},"reference-count":31,"publisher":"Society of Nuclear Medicine","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.2967\/jnumed.122.264832","type":"journal-article","created":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T20:40:20Z","timestamp":1667508020000},"page":"586-591","source":"Crossref","is-referenced-by-count":8,"title":["Differences in Failure-Free Survival After Salvage Radiotherapy Guided by Conventional Imaging Versus<sup>18<\/sup>F-Fluciclovine PET\/CT in Postprostatectomy Patients: A Post Hoc Substratification Analysis of the EMPIRE-1 Trial"],"prefix":"10.2967","volume":"64","author":[{"given":"Ismaheel O.","family":"Lawal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashesh B.","family":"Jani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omotayo A.","family":"Adediran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subir","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olayinka A.","family":"Abiodun-Ojo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishal R.","family":"Dhere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles V.","family":"Marcus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreyas S.","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viraj A.","family":"Master","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pretesh R.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph W.","family":"Shelton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omer","family":"Kucuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Hershatter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bridget","family":"Fielder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghuveer K.","family":"Halkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Schuster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2022,11,3]]},"reference":[{"key":"2023040307200709000_64.4.586.1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/JU.0000000000002757","article-title":"Clinically localized prostate cancer: AUA\/ASTRO guideline, part I: introduction, risk assessment, staging, and risk-based management","volume":"208","author":"Eastham","year":"2022","journal-title":"J Urol."},{"key":"2023040307200709000_64.4.586.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(96)00167-7"},{"key":"2023040307200709000_64.4.586.3","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.eururo.2019.03.016","article-title":"External validation of the European Association of Urology biochemical recurrence risk groups to predict metastasis and mortality after radical prostatectomy in a European cohort","volume":"75","author":"Tilki","year":"2019","journal-title":"Eur Urol."},{"key":"2023040307200709000_64.4.586.4","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.prro.2019.04.008","article-title":"Adjuvant and salvage radiation therapy after prostatectomy: ASTRO\/AUA guideline amendment, executive summary 2018","volume":"9","author":"Pisansky","year":"2019","journal-title":"Pract Radiat Oncol."},{"key":"2023040307200709000_64.4.586.5","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/s41585-021-00497-7","article-title":"Salvage therapy for prostate cancer after radical prostatectomy","volume":"18","author":"Zaorsky","year":"2021","journal-title":"Nat Rev Urol."},{"key":"2023040307200709000_64.4.586.6","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(02)02411-1"},{"key":"2023040307200709000_64.4.586.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.nucmedbio.2011.06.008"},{"key":"2023040307200709000_64.4.586.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.nucmedbio.2015.07.005"},{"key":"2023040307200709000_64.4.586.9","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.114.143628"},{"key":"2023040307200709000_64.4.586.10","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.107.040097"},{"key":"2023040307200709000_64.4.586.11","first-page":"406","article-title":"Clinical utility of 18F-fluciclovine PET\/CT in recurrent prostate cancer with very low (\u22640.3 ng\/mL) prostate-specific antigen levels","volume":"11","author":"Marcus","year":"2021","journal-title":"Am J Nucl Med Mol Imaging."},{"key":"2023040307200709000_64.4.586.12","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s11307-021-01644-7","article-title":"Positivity rate of [18F]fluciclovine PET\/CT in patients with suspected prostate cancer recurrence at PSA levels below 1 ng\/mL","volume":"24","author":"Bulbul","year":"2022","journal-title":"Mol Imaging Biol."},{"key":"2023040307200709000_64.4.586.13","doi-asserted-by":"crossref","first-page":"4463","DOI":"10.1007\/s00259-021-05415-y","article-title":"A bicentric retrospective analysis of clinical utility of 18F-fluciclovine PET in biochemically recurrent prostate cancer following primary radiation therapy: is it helpful in patients with a PSA rise less than the Phoenix criteria?","volume":"48","author":"Salavati","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2023040307200709000_64.4.586.14","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.2967\/jnumed.120.256784","article-title":"Salvage radiotherapy management decisions in postprostatectomy patients with recurrent prostate cancer based on 18F-fluciclovine PET\/CT guidance","volume":"62","author":"Abiodun-Ojo","year":"2021","journal-title":"J Nucl Med."},{"key":"2023040307200709000_64.4.586.15","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/S0140-6736(21)00581-X","article-title":"18F-fluciclovine-PET\/CT imaging versus conventional imaging alone to guide postprostatectomy salvage radiotherapy for prostate cancer (EMPIRE-1): a single centre, open-label, phase 2\/3 randomised controlled trial","volume":"397","author":"Jani","year":"2021","journal-title":"Lancet."},{"key":"2023040307200709000_64.4.586.16","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1016\/S0140-6736(21)01790-6","article-title":"The addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy (NRG Oncology\/RTOG 0534 SPPORT): an international, multicentre, randomised phase 3 trial","volume":"399","author":"Pollack","year":"2022","journal-title":"Lancet."},{"key":"2023040307200709000_64.4.586.17","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.ijrobp.2016.08.043","article-title":"Salvage radiation therapy dose response for biochemical failure of prostate cancer after prostatectomy: a multi-institutional observational study","volume":"96","author":"Pisansky","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"2023040307200709000_64.4.586.18","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.67.9647"},{"key":"2023040307200709000_64.4.586.19","doi-asserted-by":"crossref","unstructured":"Klein JP Moeschberger ML . Survival Analysis: Techniques for Censored and Truncated Data. Springer; 2003:234\u2013237.","DOI":"10.1007\/b97377"},{"key":"2023040307200709000_64.4.586.20","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.eururo.2016.08.002","article-title":"EAU-ESTRO-SIOG guidelines on prostate cancer. Part II: treatment of relapsing, metastatic, and castration-resistant prostate cancer","volume":"71","author":"Cornford","year":"2017","journal-title":"Eur Urol."},{"key":"2023040307200709000_64.4.586.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2011.10.069"},{"key":"2023040307200709000_64.4.586.22","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)00111-X"},{"key":"2023040307200709000_64.4.586.23","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.116.176057"},{"key":"2023040307200709000_64.4.586.24","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.ijrobp.2022.04.005","article-title":"Randomized trial of conventional versus conventional plus fluciclovine (18F) positron emission tomography\/computed tomography-guided postprostatectomy radiation therapy for prostate cancer: volumetric and patient-reported analyses of toxic effects","volume":"113","author":"Dhere","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"2023040307200709000_64.4.586.25","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-016-3383-8"},{"key":"2023040307200709000_64.4.586.26","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.prro.2020.05.007","article-title":"18F-fluciclovine positron emission tomography in men with biochemical recurrence of prostate cancer after radical prostatectomy and planning to undergo salvage radiation therapy: results from LOCATE","volume":"10","author":"Solanki","year":"2020","journal-title":"Pract Radiat Oncol."},{"key":"2023040307200709000_64.4.586.27","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30415-2"},{"key":"2023040307200709000_64.4.586.28","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ijrobp.2020.01.050","article-title":"Effect of 18F-fluciclovine positron emission tomography on the management of patients with recurrence of prostate cancer: results from the FALCON trial","volume":"107","author":"Scarsbrook","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"2023040307200709000_64.4.586.29","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1007\/s00259-022-05741-9","article-title":"Event-free survival after 68Ga-PSMA-11 PET\/CT in recurrent hormone-sensitive prostate cancer (HSPC) patients eligible for salvage therapy","volume":"49","author":"Ceci","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2023040307200709000_64.4.586.30","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.119.235028"},{"key":"2023040307200709000_64.4.586.31","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12885-019-5297-x","article-title":"Randomized prospective phase III trial of 68Ga-PSMA-11 PET\/CT molecular imaging for prostate cancer salvage radiotherapy planning [PSMA-SRT]","volume":"19","author":"Calais","year":"2019","journal-title":"BMC Cancer"}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.122.264832","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T14:23:49Z","timestamp":1680531829000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.122.264832"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,3]]},"references-count":31,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,4,3]]},"published-print":{"date-parts":[[2023,4]]}},"alternative-id":["10.2967\/jnumed.122.264832"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.122.264832","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,3]]}}}